Sign in
WithdrawnNo phase

Goal Management Training in Individuals With PTSD

Key facts

Who runs it
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
Jan 2023
Ended
1 Feb 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Goal Management Training (GMT)
Record updated
8 February 2023
Why it stopped
Unfortunately, we have had to prioritize other studies and we do not have the resources required to carry out this study.

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (19)Hide the full registry criteria

Who can take part

  • diagnosis of PTSD as determined by our baseline assessment
  • Due to online nature: must have access to (and ability to use) a computer/tablet with a working microphone and camera (or webcam), reliable access to a secure internet connection, and access to a quiet, private space for the assessments and group sessions
  • Ability to provide informed consent
  • Fluency in written and spoken English
  • must be resident of Ontario (due to restrictions of professional licenses)

Who cannot take part

  • ECT (electroconvulsive therapy) within the last 12 months
  • any implants, conditions, etc. that do not comply with 7T (Tesla) fMRI research safety standards (e.g., pacemaker, pregnancy/possible pregnancy)
  • history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score < 15 at the time of incident as assessed retrospectively by participant)
  • significant untreated medical illness
  • history of neurological or neurodevelopmental disorder
  • history of any pervasive developmental disorder
  • any medical disorder known to adversely affect cognition within the last 12 months
  • lifetime bipolar or psychotic disorder
  • significant dissociative disorder (as determined by our baseline assessment)
  • alcohol/substance abuse or dependence within the last 3 months
  • extensive narcotic use (e.g., fentanyl, oxycodone, etc.), use of anti-cholinergics, anti-psychotics, psychostimulants, or benzodiazepines
  • suicide attempt in last 6 months
  • pregnancy (due to impact of hormones on cognitive abilities)
  • hearing or vision issues that would interfere with effective online participation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will evaluate the effect of a manualized treatment (Goal Management Training, or GMT) on the cognitive impairments associated with PTSD (Post-Traumatic Stress Disorder), as well as any impact on PTSD symptems themselves. Participants will be randomized to either GMT group treatment, or a wait list condition.

The 2 groups in the trial

  • Goal Management Training (GMT)Treatment being tested

    Participants in this arm will attend 9 weekly, 2-hour group GMT appointments.

  • Wait ListNo study treatment, for comparison

    Participants in this arm will receive no treatment for approximately 21 weeks (at which point, they will be offered the same, standard GMT treatment).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An EffectivenessTrial Examining a Novel Approach to Cognitive Remediation in Individuals With Post-Traumatic Stress Disorder (PTSD)
Record updated
8 February 2023